The U.S. Supreme Court's decided 6-3 in Wyeth v. Levine the that state tort claims over the warning labels of pharmaceuticals could not be pre-empted by federal law simply because the U.S. Food and Drug Administration had approved the warning labels.
Fredric Eisenberg said the court's ruling was "profoundly significant" for any consumer of prescription medication. "This case involved a concerted effort by the Bush administration, working in tandem with the pharmaceutical industry, to close courthouse doors to consumers seriously injured by defective pharmaceuticals," Eisenberg said Wednesday. "Today's 6-3 decision by the Supreme Court is an unqualified rejection of that effort. As such, juries will again be asked in courtrooms around this country, and shortly here in Philadelphia, to hold pharmaceutical companies accountable."
The case was labeled by many watchers as one of the most significant business cases to go before the court this term, he said. The ruling shows that consumers, and not businesses, prevailed, Eisenberg said.
If you believe that you or a loved one have been injured as a result of dangerous or defective medication, do no hesitate to contact our law firm to speak to an experienced pharmaceutical attorney about your case.
